A pharmaceutical line can be washed and still be waiting for permission to work. Excellims builds instruments that bring the chemical answer closer to the production floor.
After years building detection systems for security work, the Excellims founder turned a fast separation technique toward a broader question: what changes when the laboratory can travel to the sample?
The Minneapolis life-sciences supplier turned a catalog of repeat-purchase reagents into a $1.2 billion business. Its best lesson is not the pending $11.3 billion exit - it is how one expensive diagnostics detour forced the portfolio back toward tools that scale.